| Serial Number | 90560221 |
| Word Mark | Q MOLECULE TO CURE. FAST. |
| Filing Date | Thursday, March 4, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 15, 2022 |
| Registration Number | 6898033 |
| Registration Date | Tuesday, November 15, 2022 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 30, 2022 |
| Goods and Services | Custom manufacture of pharmaceuticals and biopharmaceuticals; custom manufacture of pharmaceuticals and biopharmaceuticals for clinical trial purposes; manufacturing services for clinical trials, namely, manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; providing information about the results of clinical trials for pharmaceutical and biopharmaceutical products, namely, providing technical information in the field of pharmaceutical and biopharmaceutical manufacturing and testing |
| Description of Mark | The mark consists of two light grey squares next to each other. The square on the left contains a semi-circular navy blue curved line with light blue molecules floating from the semi-circle and the navy blue letter "Q" overlayed on top of the design. The square on the right contains a word-stacked stylization of the black wording "MOLECULE" on top of the black wording "TO CURE", both of which are on top of the black wording "FAST". All instances of the color white represent a background and are not claimed as a feature of the mark. |
| Goods and Services | Contract packaging services in the nature of packaging and labeling of pharmaceutical and biopharmaceuticals for distribution on behalf of third parties; packaging and labeling of products for others, namely, contract packaging services in the nature of merchandise packaging for others; storage services, namely, warehousing and temperature controlled storage of goods for others; transportation logistics services, namely, arranging transportation of goods for others; packaging articles to the order and specification of others; packaging of pharmaceutical, biopharmaceutical and clinical supplies and materials, namely, contract packaging services in the nature of pharmaceutical, biopharmaceutical and clinical supplies and materials packaging for others |
| Pseudo Mark | QUOTIENT MOLECULE TO CURE. FAST. |
| Indication of Colors claimed | The color(s) navy blue, light blue, grey and black are included as a feature of the mark or legal equivalent in the foreign registration. Similarly, in the U.S. application, the colors navy blue, light blue, grey and black is/are claimed as a feature of the mark. |
| Goods and Services | Clinical research in the field of pharmacology and medical research; clinical trials for others; conducting clinical trials for others; conducting clinical trials for others in the field of pharmaceutical and biopharmaceutical products; pharmaceutical and biopharmaceutical research services; pharmaceutical and biopharmaceutical testing services; research relating to science, namely, scientific research, basic and clinical research in the fields of pharmacology, pharmaceuticals and biopharmaceuticals; analytical services, namely, evaluation and analysis of the efficacy of pharmaceutical and biopharmaceutical products and dosages in the nature of analysis and evaluation of pharmaceutical and biopharmaceutical products and dosages of others to determine conformity with certification standards and to assure compliance with industry standards; pharmaceutical and biopharmaceutical product evaluation; providing medical and scientific research information in the field of pharmaceuticals, biopharmaceuticals and clinical trials; biological research; research and development of vaccines and medicines; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical products development; pharmaceutical and biopharmaceutical formulation design and development services, namely, development of pharmaceutical and biopharmaceutical preparations and medicines; pre-formulation screening services, namely, conducting early evaluations in the field of new pharmaceutical and testing, inspection and research of pharmaceuticals; conducting clinical trials for others for optimisation of pharmaceutical and biopharmaceutical formulations and dosage through clinical testing; development of pharmaceutical and biopharmaceutical preparations and medicines, research and development of vaccines and medicines, product research and development, product development for others, research relating to medicine, namely, medical research, basic and clinical research in the field of pharmacology; consultancy relating to pharmaceutical and biopharmaceutical testing and screening programs in particular testing, inspection and research of pharmaceuticals and biopharmaceuticals; consultancy in the field of pharmacology; clinical pharmacology, namely, technical research, testing and consulting in the field of pharmaceutical and biopharmaceutical studies; laboratory research services relating to pharmaceuticals |
| International Class | 039 - Transport; packaging and storage of goods; travel arrangement. |
| US Class Codes | 100, 105 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 3, 2021 |
| Primary Code | 039 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 3, 2021 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 3, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Quotient Sciences Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Ruddington, Nottingham NG116JS GB |
| Party Name | Quotient Sciences Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Ruddington, Nottingham NG116JS GB |
| Party Name | Quotient Sciences Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Ruddington, Nottingham NG116JS GB |
| Event Date | Event Description |
| Tuesday, November 15, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, November 15, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 30, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 30, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 10, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 26, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, July 25, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 25, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 25, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, June 13, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 13, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, June 13, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, May 9, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, May 9, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 29, 2022 | ASSIGNED TO LIE |
| Tuesday, April 26, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 29, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, October 29, 2021 | NON-FINAL ACTION E-MAILED |
| Friday, October 29, 2021 | NON-FINAL ACTION WRITTEN |
| Monday, September 27, 2021 | ASSIGNED TO EXAMINER |
| Friday, June 4, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, June 3, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, March 8, 2021 | NEW APPLICATION ENTERED IN TRAM |